Bill Ackman Will Be on CNBC's Halftime Report Today (VRX) (HLF)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Herbalife (HLF) Has 'Levers to Pull' in Next Few Weeks - Pivotal Research
July 18, 2016 9:40 AM EDTPivotal Research reiterated a Buy rating on Herbalife (NYSE: HLF) with a price target of $90. Analyst Timothy S. Ramey doesn't believe efforts to comply with FTC oversight will do much damage to its U.S. business, and he reiterated his bullish stance. He also noted that Herbalife has "several important levers to pull in the next few weeks."
"There is no doubt that the permanent injunction, entered into by the FTC and Herbalife has challenges for the company and plenty of stern language. The company will be under three-year scrutiny by the... More
Herbalife (HLF) Enters Settlement with FTC; Board Grants Icahn Ability to Boost Stake to 34.99%
July 15, 2016 8:28 AM EDTHerbalife Ltd. (NYSE: HLF) announced it has reached a settlement agreement with the Federal Trade Commission (FTC or the Commission) resolving the FTCs multi-year investigation of the Company. The terms of the settlement do not change Herbalifes business model as a direct selling company and set new standards for the industry. With the settlement agreement announced today, the FTCs investigation of Herbalife is complete.
Herbalife and the Illinois Attorney General also reached a settlement, and the Company agreed to pay $3 million as part of this separate agreement. With the conclusion of the... More
Valeant (VRX) Investors Should Be Focused on Earnings Not Upcoming Product Catalysts - Wells Fargo
July 14, 2016 1:29 PM EDTWhile Valeant Pharmaceuticals (NYSE: VRX) continues to avoid trading on fundamentals three potential catalysts lie ahead for the company. Today, Wells Fargo bearish-leaning analyst David Maris provide his thoughts ahead of these events.
The 3 events are:
Friday (7/15) advisory panel documents should become available ahead of next Tuesdays (7/19) FDA advisory panel on brodalumab;next... MoreAckman Made a 'Valiant' Effort, Time to Move On: Herbalife (HLF)
July 14, 2016 12:13 PM EDTIn a statement read on CNBC, Herbalife (NYSE: HLF) said Ackman made a 'valiant' on his short effort but it's time to move one. Clearly a stab at his blow-up in Valeant (VRX).
... MoreValeant Pharma (VRX) Shares Rise After Clarifying Recent Pearson Stock, Options Sales
July 14, 2016 9:00 AM EDTValeant Pharma (NYSE: VRX) shares are indicated higher in early trading Thursday after the company issued commentary on recent stock transactions conducted by former CEO Mike Pearson. The stock is up over 3 percent.
... More